| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |